Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$1.4 million.

  • Neuraxis' Free Cash Flow fell 217.36% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.3 million, marking a year-over-year increase of 1042.75%. This contributed to the annual value of -$6.1 million for FY2024, which is 890.32% up from last year.
  • Latest data reveals that Neuraxis reported Free Cash Flow of -$1.4 million as of Q3 2025, which was down 217.36% from -$1.5 million recorded in Q2 2025.
  • Neuraxis' 5-year Free Cash Flow high stood at -$204315.0 for Q4 2022, and its period low was -$2.8 million during Q3 2023.
  • Over the past 4 years, Neuraxis' median Free Cash Flow value was -$1.4 million (recorded in 2025), while the average stood at -$1.4 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 119486.28% in 2023, then soared by 5043.66% in 2024.
  • Quarter analysis of 4 years shows Neuraxis' Free Cash Flow stood at -$204315.0 in 2022, then tumbled by 1194.86% to -$2.6 million in 2023, then skyrocketed by 33.54% to -$1.8 million in 2024, then grew by 18.81% to -$1.4 million in 2025.
  • Its Free Cash Flow stands at -$1.4 million for Q3 2025, versus -$1.5 million for Q2 2025 and -$1.6 million for Q1 2025.